Search results
AstraZeneca Singapore is one of Singapore’s leading biopharmaceutical companies that aim to make a difference in the healthcare industry by touching and saving as many lives as we can through our innovation in the scientific medical field. Primary Contact. AstraZeneca Singapore Pte Ltd. 10 Kallang Avenue #12-10 Aperia Tower 2, Singapore 339510.
May 20, 2024 · AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody.
May 21, 2024 · SINGAPORE – Global biopharmaceutical company AstraZeneca intends to build a US$1.5 billion (S$2 billion) manufacturing facility in Singapore, the company said on May 20. It aims to begin the...
May 20, 2024 · AstraZeneca plans to build a US$1.5 billion manufacturing facility in Singapore to produce antibody-drug conjugates (ADCs) and targeted cancer therapies, the British company said on Monday (May...
May 23, 1990 · ASTRAZENECA SINGAPORE PTE LTD was incorporated on 23 May 1990 (Wednesday) as a Private Company Limited by Shares in Singapore. The Company current operating status is live with registered address at APERIA.
Oct 1, 2021 · ASTRAZENECA SINGAPORE PTE LTD. Date of Approval. 29/10/2021. Indications: Chronic kidney disease. FORXIGA is indicated as an adjunct to standard therapy to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular (CV) death in adults with chronic kidney disease at risk of progression.
Dec 3, 2021 · On 25 November 2021, AstraZeneca Singapore signed Memorandums of Understanding (MOUs) with five technology partners, in the presence of the Singapore Ministry of Health and the Swedish Ministry of Health at the Singapore-Sweden Digital Healthcare RESET Dialogue.
